Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Validation of a Body-Composition Segmentation Software (Soma) on a Diverse Cohort of Publicly Available CT Scans
Authors not listed
Nucleo Research, Inc. · 2026
Abstract
This study evaluates the standalone performance of Soma, a deep-learning software developed by Nucleo Research, Inc. for the automated segmentation of body-composition tissues (skeletal muscle, subcutaneous adipose tissue, visceral adipose tissue, and intramuscular adipose tissue) on whole-body computed tomography (CT) images. The aim is to confirm that Soma produces segmentations and tissue-area measurements that agree with a multi-rater expert reference standard, on a diverse cohort representative of demographic and clinical variation. A total of 200 CT scans are sampled by stratified design from a curated pool of 2,066 scans aggregated from six publicly available, de-identified imaging datasets (autoPET, AMOS, MSD Pancreas, CT-ORG, ENHANCE.PET, RATIC). Three board-certified radiologists independently annotate the reference standard at the L3 slice. Primary performance is assessed using the Dice similarity coefficient against the multi-rater reference, with predefined thresholds and BCa bootstrap confidence intervals, both in aggregate and within every demographic and clinical subgroup. Secondary endpoints include Bland-Altman analysis of tissue-area agreement, 95th-percentile Hausdorff distance, Pearson correlation of derived indices, and Cohen's kappa for sarcopenia classification using Skeletal Muscle Index (SMI). The study is fully retrospective on de-identified images, involves no patient contact, and has been determined exempt by Salus IRB (Salus Number 26328) under 45 CFR 46.104(d)(4).
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-25 MST
Cite this
APA
Anonymous. (2026). Validation of a Body-Composition Segmentation Software (Soma) on a Diverse Cohort of Publicly Available CT Scans. <em>Nucleo Research, Inc.</em>. https://clinicaltrials.gov/study/NCT07600866
Vancouver
Anonymous. Validation of a Body-Composition Segmentation Software (Soma) on a Diverse Cohort of Publicly Available CT Scans. Nucleo Research, Inc.. 2026.
BibTeX
@misc{anon2026Valida,
title = {Validation of a Body-Composition Segmentation Software (Soma) on a Diverse Cohort of Publicly Available CT Scans},
author = {Anonymous},
journal = {Nucleo Research, Inc.},
year = {2026},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
SingHealth Community Hospitals 2025
Open access · US-GOV
Enhancing Wellbeing in Seniors Through an Arts-Incorporated Social Prescribing Program in Rehabilitation and Community Settings: A Mixed-method Study
The Lancet Infectious Diseases 2021
Open access · CC-BY
Transcriptomic signatures for diagnosing tuberculosis in clinical practice: a prospective, multicentre cohort study
Hebrew SeniorLife 2023
Open access · US-GOV
Understanding and Modulating Cortical Dynamics of Dual-task Standing in Older Adults With Mild Cognitive Impairment
Respirology 2026
Open access · OA
Frailty, Chronological Age, and Clinical Outcomes in COPD : A Nationwide Cohort Study
University of Florida 2025
Open access · US-GOV
Neural Control of Gait & Navigation in ADRD, Aim 3 Clinical Trial
GeroScience 2017
Open access · CC-BY